BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19097948)

  • 1. Investigating the in vitro metabolism of veratridine: characterization of metabolites and involved cytochrome P450 isoforms.
    Ye X; Wang Y; Yang M; Wang Q; Liang Q; Ma Z; Zhang B; Gao Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):141-8. PubMed ID: 19097948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine.
    Wang Y; Wang S; Liu Y; Yan L; Dou G; Gao Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):292-300. PubMed ID: 16949890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Cresteil T
    J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Vanquelef E; Duval O; Sonnier M; Cresteil T
    Rapid Commun Mass Spectrom; 2004; 18(4):474-82. PubMed ID: 14966856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitive effect of diphenytriazol on rat cytochrome P450 enzyme in vitro.
    Hu YZ; Yao TW
    Pharmazie; 2009 Jul; 64(7):455-60. PubMed ID: 19694183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of nefiracetam by liver microsomes from rats, dogs and monkeys.
    Fujimaki Y; Sudo K; Hakusui H
    Arzneimittelforschung; 1995 Jul; 45(7):748-52. PubMed ID: 8573215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
    Baranczewski P; Edlund PO; Postlind H
    J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the in vitro stereoselective metabolism of m-nisoldipine enantiomers: characterization of metabolites and cytochrome P450 isoforms involved.
    Sun Y; Jia P; Yuan L; Liu Y; Zhang Z; Du Y; Zhang L
    Biomed Chromatogr; 2015 Dec; 29(12):1893-900. PubMed ID: 25994315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
    Picard N; Cresteil T; Djebli N; Marquet P
    Drug Metab Dispos; 2005 May; 33(5):689-95. PubMed ID: 15743975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of dl-praeruptorin A in rat liver microsomes using HPLC-electrospray ionization tandem mass spectrometry.
    Ruan H; Zhang Z; Liang XF; Fu Y; Su MQ; Liu QL; Wang XM; Zhu X
    Arch Pharm Res; 2011 Aug; 34(8):1311-21. PubMed ID: 21910053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
    Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
    Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of in vitro metabolites of deoxypodophyllotoxin in human and rat liver microsomes using liquid chromatography/tandem mass spectrometry.
    Lee SK; Jun IH; Yoo HH; Kim JH; Seo YM; Kang MJ; Lee SH; Jeong TC; Kim DH
    Rapid Commun Mass Spectrom; 2008; 22(1):52-8. PubMed ID: 18050240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
    Shayeganpour A; El-Kadi AO; Brocks DR
    Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteomic approach to the identification of cytochrome P450 isoforms in male and female rat liver by nanoscale liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Nisar S; Lane CS; Wilderspin AF; Welham KJ; Griffiths WJ; Patterson LH
    Drug Metab Dispos; 2004 Apr; 32(4):382-6. PubMed ID: 15039290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.